What is Energenesis Biomedical CO.,LTD.'s (6657.TW) StockRank?

MoatMap's StockRank for Energenesis Biomedical CO.,LTD. (6657.TW) is 8/100, with a Strong Sell signal. This is a composite score combining Quality (38), Value (25), and Momentum (22) factor ranks across MoatMap's 20,000+ stock universe.

Does Energenesis Biomedical CO.,LTD. have an economic moat?

Energenesis Biomedical CO.,LTD. (6657.TW) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Energenesis Biomedical CO.,LTD. a buy, hold, or sell?

MoatMap's current signal for Energenesis Biomedical CO.,LTD. (6657.TW) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Energenesis Biomedical CO.,LTD. in?

Energenesis Biomedical CO.,LTD. (6657.TW) operates in the Healthcare sector, specifically the Biotechnology industry (Taiwan).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

6657.TW

STRONG SELLREMOVE

Energenesis Biomedical CO.,LTD. · Healthcare · Taiwan · $101M · Avg Vol: $308K/d

StockRank

P/E (TTM)

—

ROE

-21.6%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Energenesis Biomedical is a small-cap biotech firm with unproven clinical pipelines and high cash burn. It lacks the scale, validated manufacturing moats, or pricing power of established CDMOs.

COMPANY DESCRIPTION

Energenesis Biomedical CO.,LTD. develops innovative therapeutics for wound healing, muscle atrophy, and metabolic diseases, utilizing its proprietary ENERGI platform. The company focuses on AMPK activator technology to address unmet medical needs in tissue repair and aging-related conditions. It is a clinical-stage biotechnology company specializing in cellular energy regulation and regenerative medicine.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	0.2M	0.2M	0.2M	0.2M	1.4%
EPS	-0.06	-0.12	-0.11	-0.10	—	—
Shares	—	67.5M	76.7M	77.2M	88.8M	+31.7%
Debt	—	0.3M	0.3M	0.3M	0.5M	15.9%
Equity	—	19.0M	25.4M	23.4M	28.3M	14.2%
Op CF	—	-7.4M	-7.1M	-5.7M	-7.0M	—
Inv CF	—	5.5M	-1.9M	6.1M	2.9M	—
Fin CF	—	-55,357	13.9M	4.6M	12.6M	—

PRICE (1Y)-11.2%

SMA 50SMA 200

$1.11

RSI (14)

38.2

52W High

$2.24

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

-28.5%23.7

ROE

-21.6%29.0

GP/Assets

0.6%11.9

Op. Margin

-3652.2%4.1

FCF/Assets

-13.0%24.6

Piotroski

430.3

Int. Cover

-50.0x6.0

D/E Ratio

0.02x84.9

Current Ratio

30.13x98.0

Value

P/E (TTM)

—N/A

EV/EBITDA

-10.8x25.0

P/FCF

—N/A

P/B

3.6x35.5

P/S

390.7x4.1

Div Yield

—N/A

Momentum

52W High %

50%26.3

RS 6M

-84%11.2

SMA 50/200

0.88x28.2

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$101M

P/E (Forward)

—

Gross Margin

75.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6657.TW are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
6657.TW	Energenesis Biomedical CO.,LTD.(you)	$101M	8	STRONG SELL
6885.TW	BRIM Biotechnology, Inc.	$91M	9	STRONG SELL
6733.TWO	BioGend Therapeutics Co., Ltd.	$102M	12	STRONG SELL
6461.TWO	Intech Biopharm Corporation	$84M	6	STRONG SELL
4178.TW	StemCyte International, Ltd.	$117M	12	STRONG SELL
MENS	Jyong Biotech Ltd.	$121M	4	STRONG SELL
6838.TW	Formosa Pharmaceuticals, Inc.	$116M	15	STRONG SELL
4174.TWO	OBI Pharma, Inc.	$116M	1	STRONG SELL
4168.TWO	GlycoNex Incorporation	$91M	17	STRONG SELL
4726.TWO	Mycenax Biotech Inc.	$160M	5	STRONG SELL

Peer medians: ROE 3.6% · P/E 16.2x · Gross margin 42.1%

Energenesis Biomedical CO.,LTD. (6657.TW) — Stock Score Summary

Energenesis Biomedical CO.,LTD. (6657.TW) has a MoatMap StockRank of 8/100 based on Quality (38/100), Value (25/100), and Momentum (22/100) factor scores. The current signal is STRONG SELL. Energenesis Biomedical is a small-cap biotech firm with unproven clinical pipelines and high cash burn. It lacks the scale, validated manufacturing moats, or pricing power of established CDMOs.

Key Financial Metrics

Price	$1.11
Market Cap	$101M
Price/Book	3.62
Return on Equity	-21.6%
Return on Invested Capital	-28.5%
Debt/Equity	1.57
Gross Margin	75.1%
Operating Margin	-3652.2%
Revenue Growth	14.7%
Free Cash Flow	$-123K

Energenesis Biomedical CO.,LTD. operates in the Biotechnology industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Energenesis Biomedical CO.,LTD.’s (6657.TW) StockRank?: MoatMap’s StockRank for Energenesis Biomedical CO.,LTD. (6657.TW) is 8/100, with a Strong Sell signal. It is a composite of Quality (38), Value (25), and Momentum (22) factor ranks across MoatMap’s 20,000+ stock universe.
Does Energenesis Biomedical CO.,LTD. have an economic moat?: Energenesis Biomedical CO.,LTD. (6657.TW) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Energenesis Biomedical CO.,LTD. a buy, hold, or sell?: MoatMap’s current signal for Energenesis Biomedical CO.,LTD. (6657.TW) is Strong Sell, based on a StockRank of 8/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Energenesis Biomedical CO.,LTD. in?: Energenesis Biomedical CO.,LTD. (6657.TW) operates in the Healthcare sector, specifically the Biotechnology industry (Taiwan).